Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients-Reference-Cited by-同舟云学术

Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients

Published:2013-11-20 Issue:5 Volume:21 Page:473-478
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Kimura Takahiro¹,Kido Masahito¹,Miki Kenta¹,Yamamoto Toshihiro¹,Sasaki Hiroshi¹,Kuruma Hidetoshi¹,Hayashi Norihiro¹,Takahashi Hiroyuki²,Aoki Manabu³,Egawa Shin¹

Affiliation:

1. Department of Urology; Jikei University School of Medicine; Tokyo Japan

2. Department of Pathology; Jikei University School of Medicine; Tokyo Japan

3. Department of Radiology; Jikei University School of Medicine; Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.12347/fullpdf

Reference22 articles.

1. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer;Potters;J. Urol.,2005

2. Influence of pretreatment and treatment factors on intermediate to long-term outcome after prostate brachytherapy;Stone;J. Urol.,2011

3. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I125 prostate brachytherapy in clinically localized prostate cancer: Seattle experience;Sylvester;Int. J. Radiat. Oncol. Biol. Phys.,2011

4. Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy;Taira;Int. J. Radiat. Oncol. Biol. Phys.,2011

5. Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer;Uesugi;Int. J. Radiat. Oncol. Biol. Phys.,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of unfavorable findings in intermediate‐risk prostate cancer patients for predicting treatment outcomes after contemporary, dose‐escalated multimodal radiotherapy;The Prostate;2021-12-16

2. Prognostic value of PSA bounce after definitive radiotherapy revisited;International Journal of Clinical Oncology;2021-10-22

3. How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?;International Journal of Clinical Oncology;2021-10-02

4. Ten‐step method of high‐dose LDR 125 I brachytherapy for intermediate‐risk prostate cancer;Journal of Applied Clinical Medical Physics;2021-05-03

5. 125I brachytherapy in younger prostate cancer patients;Strahlentherapie und Onkologie;2017-05-09